Table 1.
Disease | Study | Study title | N | Mean age (range), years | SBI (%) |
---|---|---|---|---|---|
AIS | Boon et al. (1994)16 | Silent brain infarction in 755 consecutive patients with first-ever supratentorial ischemic stroke. Relationships with index-stroke subtype, vascular risk factors and mortality | 755 | 71 | 27 |
Brainin et al. (1995)13 | Silent brain infarcts and transient ischemic attacks: a three-year study of first-ever ischemic stroke patients: the Klosterneuburg stroke data bank | 728 | 68 ± 10 | 11 | |
Chodosh et al. (1988)17 | Silent stroke in the NINCDS stroke data bank | 1203 | 69.1 | 11 | |
Corea et al. (2001)18 | Silent infarcts in stroke patients: patient characteristics and effect on 2-year outcome | 202 | 70.05 | 25.7 | |
Corea et al. (2002)19 | Brain CT scan in acute stroke patients: silent infarcts and relation to outcome | 191 | 76 | 37.8 | |
Coutts et al. (2005)20 | Silent ischemia in minor stroke and TIA patients identified on MR imaging | 143 | – | 9.8 | |
Davis et al. (1996)21 | Silent cerebral infarction in patients enrolled in the TOAST study | 629 | 65 | 22.7 | |
Giele et al. (2004)9 | Silent brain infarcts in patients with manifest vascular disease | 308 | 58 | 17 | |
Herderschee et al. (1992)22 | Silent stroke in patients with TIA or minor ischemic stroke | 2329 | 13 | ||
Jorgensen et al. (1994)14 | Silent infarction in acute stroke patients: prevalence, localization, risk factors and clinical significance: the Copenhagen Stroke Study | 322 | 73 ± 12 | 32.5 | |
Kang et al. (2006)23 | Silent ischemic lesion recurrence on MRI predicts subsequent clinical vascular events | 104 | – | 33.7 | |
Kase et al. (1989)24 | Prevalence of silent stroke in patients presenting with initial stroke: the Framingham Study | 124 | 46 | 10 | |
Liebetrau et al. (2004)25 | Silent and symptomatic infarcts on cranial computerized tomography in relation to dementia and mortality: a population-based study in 85-year-old subjects | 239 | All 85 | 8.6 | |
Minn et al. (2005)6 | Significance of silent infarcts in acute ischaemic stroke patients aged 80 years or older | 50 | ≥ 80 | 76 | |
Oh et al. (2010)26 | The prevalence and risk factor analysis of silent brain infarcts in patients with first-ever stroke | 395 | 63.8 | 33.4 | |
Ong et al. (2009)10 | Impact of silent infarction on the outcome of stroke patients | 226 | 68 ± 13 | 20 | |
Ricci et al. (1993)27 | Silent brain infarction in patients with first-ever stroke. A community based study in Umbria, Italy | 209 | 71 | 38.3 | |
Vermeer et al. (2002)11 | Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study | 1077 | 75 | 24 | |
Vermeer et al. (2003)2 | Silent brain infarcts and white matter lesions increase stroke risks in the general population: the Rotterdam Scan Study | 668 | 71 ± 7 | 14 | |
CAD | Geerlings et al. (2010)28 | Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART study | 1044 | 58 ± 10 years | 10 |
Giele et al. (2004)9 | Silent brain infarcts in patients with manifest vascular disease | 308 | 18–79 | 17 | |
Hara et al. (1994)7 | Silent cerebral infarction associated with coronary artery disease | 50 | – | 80 | |
Hoshide et al. (2001)29 | Different patterns of silent cerebral infarct in patients with coronary artery disease or hypertension | 107 | 62 | 46 | |
Kozdag et al. (2008)30 | Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy | 72 | 50–74 | 39 | |
Nadareishvili et al. (1999)31 | Cerebral microembolism in acute myocardial Infarction | 112 | 68 ± 11 years | 15 | |
Ozeren et al. (1998)32 | Silent cerebral lesions on MRI in subjects with CAD | 72 | 43 | ||
Pardo et al. (1998)33 | Silent brain infarctions in patients with coronary artery disease. A Spanish population survey | 100 | 34–82 | 30 | |
Selvetella et al. (2003)34 | Left ventricular hypertrophy is associated with asymptomatic cerebral damage in hypertensive patients | 195 | 67 ± 1 years | 55 | |
Siachos et al. (2005)35 | Silent strokes in patients with heart failure | 117 | 51 | 34 | |
Uekita et al. (2003)36 | Cervical and intercranial atherosclerosis and silent brain infarction in Japanese patients with CAD | 133 | – | 58 | |
PAD | Geerlings et al. (2010)28 | Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART study | 1044 | 58 ± 10 years | 5 |
Giele et al. (2004)9 | Silent brain infarcts in patients with manifest vascular disease | 58 | 18–79 | 21 |
TIA, transient ischaemic attack; NINCDS, National Institute of Neurological and Communicative Disorders and Stroke; CT, computed tomography; SBI, silent brain infarction; CAD, coronary artery disease; PAD, peripheral artery disease; AIS, acute ischaemic stroke; TOAST, Trial of Org 10172 in Acute Stroke Treatment; MRI, magnetic resonance imaging; SMART, Second Manifestation of ARTerial disease study; SMART-MR, Second Manifestation of ARTerial disease in Magnetic Resonance